Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Eczema / Psoriasis, Medical News

Can-Fite Initiates Preparatory Work For Psoriasis Phase III Trial With CF101

Submitted by MedicalReplies on Thursday, 1 October 2009No Comment

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis.

Read the original here:
Can-Fite Initiates Preparatory Work For Psoriasis Phase III Trial With CF101

You may also like:

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

*
To prove you're a person (not a spam script), type the security word shown in the picture.
Anti-spam image